Open AccessPercutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies
Author(s) -
Timothy C. Huber,
Teodora Bochnakova,
Yilun Koethe,
Brian Park,
Khashayar Farsad
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s268300
Subject(s) - hepatocellular carcinoma , percutaneous , cryoablation , medicine , radiofrequency ablation , microwave ablation , irreversible electroporation , malignancy , ablative case , ablation , stage (stratigraphy) , treatment modality , radiology , oncology , electroporation , radiation therapy , paleontology , biochemistry , chemistry , biology , gene
Percutaneous ablation is a mainstay of treatment for early stage, unresectable hepatocellular carcinoma (HCC). Recent advances in technology have created multiple ablative modalities for treatment of this common malignancy. The purpose of this review is to familiarize readers with the technical and clinical aspects of both existing and emerging percutaneous treatment options for HCC.